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Abstract
Similar to the brain, the eye is considered an immune-privileged
organ where tissue-resident macrophages provide the major
immune cell constituents. However, little is known about spatially
restricted macrophage subsets within different eye compartments
with regard to their origin, function, and fate during health and
disease. Here, we combined single-cell analysis, fate mapping, para-
biosis, and computational modeling to comprehensively examine
myeloid subsets in distinct parts of the eye during homeostasis. This
approach allowed us to identify myeloid subsets displaying diverse
transcriptional states. During choroidal neovascularization, a typical
hallmark of neovascular age-related macular degeneration (AMD),
we recognized disease-specific macrophage subpopulations with
distinct molecular signatures. Our results highlight the heterogene-
ity of myeloid subsets and their dynamics in the eye that provide
new insights into the innate immune system in this organ which
may offer new therapeutic targets for ophthalmological diseases.
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Introduction
Nature has found a way to provide vitally important tissues of the
body with immune protection against invading pathogens in a way
that greatly reduces the inflammatory response. Beside the brain,
certain compartments of the eye such as cornea, lens, retinal
pigment epithelium and neural retina, as well as the placenta,
ovaries, and testis belong to these tissues. This important feature,
known as “immune privilege”, is based on several molecular,
microanatomical, and cellular factors that constitute and maintain
immune protection in a given tissue (Bechmann, 2005).
Several compartments of the eye reside behind specialized
blood–tissue barriers that are formed by tight junctions between
endothelial cells and other structural specializations, such as tight
junctions among ocular pigment epithelial cells (Streilein, 2003).
However, these blood–ocular barriers are quite diverse in their loca-
tion, anatomy, local immune-skewing properties, and the immune
cells involved (Shechter et al, 2013). For example, the inner blood–
retinal barrier, localized within the inner layers of the neural retina,
is formed by non-fenestrated endothelial cells, connected by tight
junctions and covered by pericytes and astrocyte end feet. In
contrast, the blood–aqueous barrier that can be found at the ciliary
body consists of fenestrated endothelial cells on the one side,
whereas tight junctions connect non-pigmented ciliary epithelium
on the side proximal to the aqueous humor (Kaur et al, 2008).
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Finally, the cornea and the anterior chamber are specialized
immune-privileged sites of the eye that are transparent and avascu-
lar while other compartments lack blood–tissue barriers such as the
choroid or conjunctiva. Despite their different localizations and
structures, all immune-privileged compartments of the eye including
cornea, ciliary body, and retina share the presence of specialized
innate immune effectors, such as macrophages, that are involved in
immune regulatory mechanisms (Shechter et al, 2013). In general,
local tissue macrophages are considered as the key regulators ensur-
ing proper tissue homeostasis and immune defense (Varol et al,
2015; Prinz et al, 2019).
Unlike microglia and CNS macrophages (MΦ) at interfaces like
perivascular (pv), choroid plexus (cp), and meningeal (m) MΦ,
which are derived from yolk sac precursors before birth (Ginhoux
et al, 2010; Schulz et al, 2012; Kierdorf et al, 2013a; Goldmann et al,
2016; Kierdorf et al, 2019; Jord~ao et al, 2019), the macrophages
found in the cornea, ciliary body, and even the retina were
described to originate from short-lived blood monocytes after birth
that are quickly replaced by bone marrow (BM)-derived cells (Xu
et al, 2007; Kezic et al, 2008; Chinnery et al, 2008). These assump-
tions were made on the basis of immunohistochemical (Hume et al,
1983) or electron microscopy experiments (Gloor, 1969) that did not
allow for longitudinal studies of labeled cells. The assumption of a
postnatal origin of eye macrophages was also supported by the fact
that retinal microglia increase in numbers around birth and during
the first postnatal week (Santos et al, 2008). The systemic transplan-
tation of genetically engineered BM-derived cells resulted in macro-
phage engraftment in the inner and outer plexiform layers, the
ganglion cell layer and the optic nerve, but not in the photoreceptor
layer of the retina (Boettcher et al, 2008). As these experiments used
irradiation as conditioning paradigm and injection of BM cells that
are not normally present in the circulation, the engraftment of BM
cells in the preconditioned eye is likely a result of changes of the
blood–ocular barrier and concomitant local induction of chemoat-
tractants as described before for the brain (Mildner et al, 2007; Kier-
dorf et al, 2013b). Just recently, our knowledge about the origin and
turnover of eye macrophages started to change. Using pulse labeling
and fate mapping strategies, retinal microglia were shown to origi-
nate from the primitive hematopoiesis in the yolk sac while the
origin of other macrophages in the eye remains unknown (O’Koren
et al, 2019). Additionally, retinal microglia as well as macrophages
in the iris/ciliary body were suggested to be long-lived whereas
macrophages in the choroid and optic nerve showed a time-depen-
dent turnover (O’Koren et al, 2019). Interestingly, depleted retinal
microglia can be partially replenished by ciliary body macrophages
ex vivo (Huang et al, 2018). Therefore, it is of interest to identify the
origin of eye macrophages beside retinal microglia and understand
the sources, kinetics, and functions of the myeloid subsets in the
eye during health and disease in detail. From a functional point of
view, macrophages in the cornea were found to balance the
inflammatory response and wound healing after damage (Liu et al,
2017). Retinal microglia are essential to maintain a functional integ-
rity of the retina (Wang et al, 2016). Consequently, a disturbed
homeostasis of these cells is associated with neurodegeneration (Ma
et al, 2019). Notably, patients suffering from age-related macular
degeneration (AMD) display impaired retinal integrity with local
myeloid cell activation and accumulation surrounding choroidal
neovascularization (CNV), which can be modeled in rodents, e.g.,
in the laser-induced CNV model (Oh et al, 1999). This model covers
important features of neovascular AMD found in patients, namely
the sprouting of new choroidal vessels preceded by an activation of
the resident innate immune system. However, so far the differential
functions of resident retinal microglia vs. recruited monocytes and
their underlying context-dependent functions during the develop-
ment of CNV remain poorly defined due to the lack of appropriate
cell-specific in vivo models.
In this study, a combination of single-cell RNA sequencing
(scRNA-seq), embryonic and adult cell fate mapping, parabiosis,
and use of reporter mouse lines allowed us to thoroughly compare
the transcriptional profiles, origin and turnover characteristics of
retinal microglia, and resident macrophages in the ciliary body and
cornea. In addition, in a model of CNV, we were able to identify
new disease-associated myeloid subpopulations that may represent
a novel target for the treatment of AMD.
Results
Molecular survey of myeloid populations in the eye
The eye shows a remarkable anatomical compartmentalization
reflecting the multimodal functions of the ocular visual system
(Fig 1A). To comprehensively characterize the myeloid cells in the
eye, we first asked how transcriptionally similar retinal microglia
(rMG), ciliary (cbMΦ), and corneal macrophages (cMΦ) are. For
this purpose, we purified the CD45+CD3CD19Ly6G cell fractions
from the carefully dissected and separated cornea, ciliary body, and
retina for morphological examination in parallel to scRNA-seq of the
sorted cells as described before (Jord~ao et al, 2019; Masuda et al,
2019; Sankowski et al, 2019). In the retina, we consistently found
smaller CD45+CD3CD19Ly6G myeloid cells with basophilic cyto-
plasm, while cells in the ciliary body and cornea showed a classical
macrophage/monocyte appearance (Fig 1B). The morphological
diversity of myeloid cells in the investigated eye compartments was
also reflected in our scRNA-seq results that allowed us to clearly
distinguish between microglia, macrophages, and a minor propor-
tion of periphery-derived leukocytes as shown before (Jord~ao et al,
2019; Sankowski et al, 2019) (Fig 1C). We performed the mCel-Seq2
protocol followed by analysis using the RaceID3 algorithm (Herman
et al, 2018). After the exclusion of contaminating cells consisting of
neuronal cells from the retina and epithelial cells mostly from
the cornea (Fig EV1), we identified 17 distinct clusters using the
t-distributed stochastic neighbor embedding (t-SNE) algorithm.
Here, we found either microglial (three clusters), macrophage (nine
clusters), or peripheral leukocyte gene expression signatures (five
clusters) based on previously described cell type-associated genes
(Jord~ao et al, 2019) (Fig 1D). These clusters were differently
enriched in the distinct compartments (Fig 1E and F). Clusters 13,
14, and 15 were exclusively derived from the retina and represent
three distinct transcriptional cell states. As an example, cluster 13
shows the highest expression of cathepsin S and D (Ctss, Ctsd)
suggesting active processing of phagocytosed antigen reflected by
the presence of photoreceptor genes (Rho, Gnat1). The clusters 2, 3,
6, 9, and 16 were significantly enriched in the cornea and the clus-
ters 1, 5, 10, 11, and 12 in the ciliary body based on hypergeometric
testing with a cutoff of adjusted P-value <0.05 (Fig 1F).
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Subsequent GO term analysis revealed functional similarities that
were common in all compartments, e.g., “phagocytosis” or
“mononuclear cell proliferation” (Fig EV2). Of note, other GO terms
were only present in single clusters like “monoamine transport” in
the rMG cluster 15 or “positive regulation of leukocyte tethering or
rolling” in cluster 11, likely being monocytic cells, expressing Plac8
and Ly6c2 (Figs 1G and EV2). Transcripts known to be predomi-
nantly expressed by microglia (Cx3cr1, P2ry12, Tmem119, Hexb)
were enriched in clusters 13, 14, and 15 of scRNA-seq data repre-
senting rMG (Fig 1G and H).
Next, we compared eye macrophages with brain macrophages
(Jord~ao et al, 2019). We found that retinal and brain microglia are
transcriptionally very similar by sharing a cluster (0) exclusively
composed of brain- and retina-derived cells (Fig EV3A–D). Besides
several clusters of mixed composition, three of them (3, 4, 5) appear
to be significantly enriched with cells from the ciliary body by
hypergeometric testing with no contribution from the retina
(Fig EV3C). While the microglial cluster 0 clearly overlaps with the
“microglia” signature plot, the ciliary body cluster 3 shows an asso-
ciation with the signature of “border-associated macrophages” and
“monocytes” (Fig EV3E).
In line with that, our bulk RNA-seq analysis of brain microglia
(bMG), rMG, bone marrow monocytes (BM-Mo), and cMΦ
supported our findings of cell type-specific transcriptional profiles
with rMG and bMG being transcriptionally similar (Fig 2). Compara-
tive transcriptional profiling and principal component analysis
(PCA) revealed that cMΦ were more comparable to BM-Mo and
clearly separated from bMG and rMG, which both clustered together
(Fig 2A–C). As expected, all examined myeloid subtypes expressed
Ptprc (CD45), Itgam (CD11b), and Csf1r (CD115) (Fig 2D).
For protein validation of microglia- and macrophage-specific
target genes, we used Cx3cr1GFP/+ mice that harbor a targeted
replacement of a Cx3cr1 chemokine receptor allele with a cDNA
encoding enhanced green fluorescence protein (eGFP) (Jung et al,
2000). In the healthy rodent brain, only microglia and CNS-associ-
ated macrophages (CAMs) such as pvMΦ, cpMΦ, and mMΦ express
this marker (Goldmann et al, 2016; Hagemeyer et al, 2016). We
were able to identify CX3CR1
+ cells in different compartments of the
eye but the expression of P2RY12 and TMEM119 was strictly limited
to rMG, thereby confirming our scRNA- and bulk RNA-seq data
(Figs 1G and H, and 2E). In contrast, genes involved in antigen
presentation, such as Cd74 and H2-Aa, encoding the alpha chain of
the MHC class II protein, and the mannose receptor CD206 (Mrc1)
were only expressed by macrophages on both transcriptional and
protein levels, but absent in rMG (Figs 1G and I, and 2F and G).
Next, we extended our validation experiments with fluorescent
reporter mouse lines (Fig 2G). In Itgax-DTR-GFP mice, we detected
a low fraction of Iba1+CD11c+ cells throughout the retina but also in
the cornea, as described before (Hamrah et al, 2003; Dando et al,
2016; Fig 2G). In a novel HexbtdT/tdT reporter mouse model, virtu-
ally all rMG were labeled but also cMΦ, to a certain extent underlin-
ing the common myeloid nature of these cell types despite their
overall diverse expression signatures (Masuda et al, 2020; Fig 2G).
Taken together, these data reveal the existence of heterogeneous
myeloid subsets in the healthy eye, reflected by distinct morphology
and transcriptional signatures validated by the corresponding
protein expression.
Prenatal origin of eye macrophages in different compartments
In the past, the origin of myeloid cells in the eye was mainly investi-
gated by the use of lethally irradiated mice undergoing BM trans-
plantation to follow the fate of blood-derived myeloid cells as a
putative source of rMG (Xu et al, 2007; Boettcher et al, 2008), cMΦ
(Chinnery et al, 2008; Liu et al, 2017), and cbMΦ (Kezic et al,
2008). We were able to recapitulate these findings and found donor-
derived Iba1+GFP+ rMG mostly in the inner plexiform layer (IPL) of
irradiated wild-type hosts that received BM cells from Acta1GFP/+
mice (Fig 3A–D).
In several organs, including the brain, resident macrophages
arise from embryonic precursors in the yolk sac or fetal liver that
seed the tissue before birth (Schulz et al, 2012; Yona et al, 2013;
Kierdorf et al, 2013a; Molawi et al, 2014; Goldmann et al, 2016;
Hagemeyer et al, 2016; Ensan et al, 2016). In order to circumvent
◀ Figure 1. Molecular census of myeloid cells in different compartments of the healthy mouse eye.
A Scheme of the murine eye.
B Schematic diagram depicting the workflow for the isolation of single CD45+CD3CD19Ly6G cells from different eye compartments (retina, ciliary body, cornea)
under healthy conditions for unbiased single-cell RNA-seq (scRNA-seq). Morphological heterogeneity of sorted myeloid cells revealed by May-Gr€unwald-Giemsa
stained cytospins. Scale bars represents 10 µm.
C t-SNE representation of individual hematopoietic cells from all eye compartments measured by scRNA-seq. Each dot represents an individual cell. Color code
indicates the respective cell types.
D Unbiased cluster analysis of subpopulations of cells found in the steady-state adult retina (cluster 13, 14, 15), ciliary body (cluster 1, 5, 10, 11, 12), cornea (cluster 2, 3,
6, 9, 16) and of mixed composition (4, 7, 8, 17) could be identified as microglia (cluster 13, 14, 15), macrophages (cluster 1, 2, 3, 6, 7, 8, 9, 10, 16), or peripheral blood
leukocytes (cluster 4, 5, 11, 12, 17).
E t-SNE representation of single cells based on the tissue of origin.
F Stacked bar plot (Marimekko chart) representation of macrophage subsets to a given cluster demonstrating pure microglia populations in clusters 13, 14, and 15.
Hypergeometric testing revealed significantly enriched macrophage clusters in the cornea (2, 3, 6, 9, 16) and the ciliary body (1, 5, 10, 11, 12) as indicated by asterisks
(*P < 0.05, **P < 0.01, ***P < 0.001).
G Heatmap of the most regulated genes per cluster (adjusted P-value < 0.05 based on the negative binomial distribution). Clusters are arranged from the left to the
right and represent microglia (light green), macrophages (purple), and monocytes/granulocytes/lymphocytes (gray). The scale bar represents color-coded z-scores.
Genes that were subsequently confirmed on protein level in (H) and (I) are highlighted by asterisks.
H Above: t-SNE representation of P2ry12 and Tmem119 expression. Below: immunofluorescence images for P2RY12 (red) and TMEM119 (red) in CX3CR1
+ (green) retinal
microglia (outer plexiform layer) but not in CX3CR1
+ cells in the ciliary body and the peripheral stroma and epithelium of the cornea. Representative images out of
three animals are shown. Scale bars represent 50 µm.
I Above: t-SNE plots for Cd74 and H2-Aa expression. Below: Typical immunofluorescence pictures for CD74 (red) and MHCII (H2-Aa) (red) in CX3CR1
+ (green) cells in the
ciliary body and the peripheral stroma and epithelium of the cornea. Two animals were examined. Scale bars represent 50 µm.
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the irradiation-induced artifacts of BM chimeras, we used tamoxifen
(TAM)-inducible Cx3cr1CreERT2:Rosa26-YFP mice for the investiga-
tion of a potential prenatal origin of eye macrophages in an embry-
onic fate mapping approach as described before (Goldmann et al,
2016; Fig 3E–G). By doing so, it was possible to follow irreversibly
recombined long-living CX3CR1
+YFP+Iba1+ cells from embryonic
day 9 (E9.0) to postnatal day 0 (P0) in the retina, ciliary epithelium,
and the cornea (Fig 3F and G). At P0, Iba1+ rMG showed the highest
percentage of YFP+ cells (51.36  5.7%) among the investigated eye
macrophage populations comparable to the labeling rates we have
shown before for bMG and CAMs such as pvMΦ and mMΦ using a
similar approach (Goldmann et al, 2016). Of note, rMG were
described before to emerge from the yolk sac which was shown with
the Runx1-Mer-Cre-Mer mouse model (O’Koren et al, 2019). In addi-
tion, we identified for the first time pulse-labeled cbMΦ
(32.0  8.8%) in the developing ciliary body, called ciliary epithe-
lium, and cMΦ (22.26  7.1%) in the cornea (Fig 3G). In conclu-
sion, all investigated compartments of the murine eye contained
macrophages (rMG, cbMΦ, and cMΦ) of prenatal origin that derive
either from the yolk sac and/or the fetal liver to various degrees.
Different turnover of macrophage subsets in the
healthy adult eye
Macrophages in the brain are located either inside the brain
parenchyma like microglia or at CNS interfaces like CAMs (Kierdorf
et al, 2019). These compartments are separated by the blood–brain
barrier and, as a consequence, macrophages residing behind this
barrier are long-lived and self-maintained with only limited random
expansion under physiological conditions (Tay et al, 2017).
To investigate the turnover of macrophages in different compart-
ments of the eye during steady state, we compared the turnover of
rMG with cbMΦ and cMΦ in adult mice. At the age of 6 weeks, we
injected Cx3cr1CreERT2:Rosa26-YFP mice subcutaneously twice with
TAM to specifically label long-living macrophages while short-lived
myeloid cells like monocytes lose the label over time (Goldmann
et al, 2013; Wieghofer et al, 2015). Next, we quantified the YFP
expression in rMG, cbMΦ, and cMΦ at 2, 12, and 24 weeks after
TAM administration (Fig 4A–C). Flow cytometry revealed long-term
YFP expression of CD45+CD11b+ rMG (2 weeks: 91.54  2.98%,
12 weeks: 92.13  2.08%, 24 weeks: 96.30  1.62%), which is
reminiscent of the low turnover that has been described in the same
model for bMG and CAMs such as pvMΦ and mMΦ (Goldmann
et al, 2016). CD45+CD11b+CD64+F4/80+ cbMΦ also showed long-
term YFP expression (2 weeks: 82.23  6.33%, 12 weeks:
69.17  7.33%, 24 weeks: 76.90  5.18%) resembling previous
results (O’Koren et al, 2019). In contrast, the percentage of YFP+
cells among CD45+CD11b+CD64+F4/80+ cMΦ strongly dropped over
time (2 weeks: 66.91  7.10%, 12 weeks: 28.39  4.31, 24 weeks:
17.32  2.03%) comparable to the short-lived nature of choroidal
macrophages (O’Koren et al, 2019).
In line with these results, Flt3Cre:Rosa26-YFP mice, labeling all
descendants from the definitive hematopoiesis, showed the highest
recombination in cMΦ (12 weeks: 62.24  5.92%, 52 weeks:
72.55  2.6) but only low labeling in cbMΦ (12 weeks: 12.61 
0.2%, 52 weeks: 16.7  4.1) that was virtually undetectable in rMG
(12 weeks: 0.1  0.04%, 52 weeks: 0.05  0.03%) by flow cytome-
try (Fig 4D–F). Of note, Flt3Cre mice are known to target also the
prenatal definitive hematopoiesis in the fetal liver, beside the BM in
adulthood (Perdiguero et al, 2014). We therefore aimed to confirm
our findings from the Cx3cr1CreERT2:Rosa26-YFP mice by exclusively
targeting peripheral blood monocytes without a contribution of the
fetal liver and without compromising the blood–ocular barriers as in
irradiated BM chimeras. Subsequently, we generated parabiotic
mice and analyzed them 2, 12, and 20 weeks after pairing of
Acta1GFP/+ with Acta1+/+ mice (Fig 5A–D). Notably, we did not
detect any GFP+Iba1+ rMG in the Acta1+/+ partner and only low
numbers in cbMΦ (2 weeks: 0.27  0.18%, 12 weeks:
0.62  0.31%) (Fig 5A–D). In contrast, the frequency of GFP+Iba1+
cMΦ coming from the parabiotic partner steadily increased over
time (2 weeks: 0.46  0.28%, 12 weeks: 5.62  2.27%, 20 weeks:
11.30  2.80%) confirming a contribution of blood-derived cells
from the definitive hematopoiesis to this particular macrophage
population (Fig 5A and D).
To gain more insight into the identity of the cell type in the
peripheral blood contributing to the high turnover of cMΦ, we next
◀ Figure 2. Comparative bulk RNA-seq analysis of microglia from brain and retina, cornea macrophages, and bone marrow-derived monocytes.
A Heatmap of differentially expressed genes between rMG, bMG, cMΦ, or bone marrow-derived monocytes (BM-Mo). The mean centered and s.d. scaled expression
values for genes that were significantly and at least twofold more or less abundantly expressed are shown. See Fig EV4 for gating strategy. Data are derived from four
independent experiments with 5–10 pooled mice per sample and shown as mean  s.e.m.
B Principal component analysis of myeloid cell transcripts analyzed by RNA-seq. Data are derived from four independent experiments with 5–10 pooled mice per
sample and shown as mean  s.e.m.
C Comparison of functional gene clusters between BM-Mo, cMΦ, and rMG in comparison with bMG (reference population). Data are derived from four independent
experiments with 5–10 pooled mice per sample and shown as mean  s.e.m.
D Left, spider plots showing commonly expressed genes across macrophages in comparison with bMG (reference population, center). Bold genes were plotted as bar
graph on the right. Four samples were analyzed per cell type. Data are derived from four independent experiments with 5–10 pooled mice per sample and shown as
mean  s.e.m.
E Left, spider plots showing genes highly enriched in microglia in comparison with bMG (reference population, center). Bold genes are plotted as bar graphs on the
right. Data are derived from four independent experiments with 5–10 pooled mice per sample and shown as mean  s.e.m.
F Left, spider plots showing genes commonly expressed by monocytes and/or cMΦ in comparison with bMG (reference population, center). Bold genes are plotted as
bar graphs (right). Data are derived from four independent experiments with 5–10 pooled mice per sample and shown as mean  s.e.m.
G Left, bar graphs showing expression of the genes Mrc1, Itgax, and Hexb in rMG, bMG, cMΦ, or bone marrow-derived monocytes (BM-Mo). Right, validation of Mrc1
(CD206) in Cx3cr1-GFP mice, Itgax in Itgax-GFP mice, and Hexb in Hexb-Tomato mice in the cornea and the retina. Arrows point to CX3CR1
+CD206+ cMΦ (top row) or
Iba1+CD11c+ cMΦ or rMG (middle row) or Iba1+Hexb+ cMΦ or rMG (bottom row). Asterisks point CX3CR1
+CD206 cMΦ (top row) or Iba1+CD11c cMΦ or rMG
(middle row) or Iba1+Hexb cMΦ or rMG (bottom row). Data are derived from four independent experiments with 5–10 pooled mice per sample and shown as
mean  s.e.m. Scales bar represents 50 µm.
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investigated Ccr2-RFP mice, in which all short-lived CCR2+ mono-
cytes and their descendants express the red fluorescent protein
(RFP) (Saederup et al, 2010; Fig 5E–I). Again, we did not detect any
rMG and only few cbMΦ that expressed RFP by flow cytometry
(4.93  1.37%) (Fig 5E–H) or confocal microscopy (Fig 5J). In
contrast, up to one third of cMΦ expressed RFP as quantified by
flow cytometry (28.94  2.96%) which is in line with previous
reports (Liu et al, 2017) and our microscopical evaluation (Fig 5E, H
and J). All circulating Ly6Chi and Ly6Clo monocytes expressed RFP
serving as a positive control (Fig 5E and I) (Saederup et al, 2010).
The low Cre recombination of rMG and cbMΦ in Flt3Cre:Rosa26-YFP
animals suggests that their development occurred largely indepen-
dent of Flt3+ multipotent hematopoietic precursors in the BM. On
the contrary, the high turnover in Cx3cr1CreERT2:Rosa26-YFP mice,
the strong labeling in Flt3Cre:Rosa26-YFP and Ccr2-RFP mice and the
time-dependent increase of GFP+ cells during parabiosis is strongly
indicative of a role of hematopoietic stem cells in the maintenance
of cMΦ.
In sum, these data clearly show different turnover kinetics of
macrophages in distinct compartments of the healthy eye, namely
that rMG and cbMΦ share their longevity with microglia and CAMs
in the brain that have no or negligible input from blood monocytes.
In contrast, cMΦ are characterized by a dual origin. They are initi-
ally composed of yolk sac-derived cells; however in adult mice,
cMΦ are continuously replaced with cells derived from the definitive
hematopoiesis with a short turnover.
Spatial and temporal distribution of myeloid cell subsets during
the formation of choroidal neovascularization
To investigate the kinetics of myeloid cell subsets and the appear-
ance of disease-associated cell populations during retinal pathology,
we used a model of experimental CNV. This model is characterized
by the formation of new vessels, which mimics the main hallmark of
neovascular AMD in humans. For this purpose, CNV was induced by
laser treatment in Cx3cr1CreERT2:Rosa26-tdTomato mice 8 weeks after
TAM treatment (Fig 6A). In vivo funduscopic imaging of untreated
non-lesioned mice revealed no signs of retinal damage and tomato+
rMG were evenly distributed in the retina (Fig 6B). Notably, the
corresponding retinal pigment epithelium (RPE) was devoid of any
Iba1+tomato+ myeloid cells in non-lesioned mice (Fig 6B). At 7 days
after laser treatment, laser-induced lesions were clearly apparent and
tomato+ rMG were increased at the lesion site (Fig 6C). In parallel,
fluorescence angiography showed a marked leakage of fluorescein
caused by the newly formed immature vessels (Fig 6C). The cellular
composition of infiltrating cells changed dramatically after laser-
induced CNV formation in comparison with the control mice. First,
Iba1+tomato+ rMG in the retina were morphologically altered with
fewer ramifications and Iba1+tomato recruited macrophages
entered the lesioned eye (Fig 6C). Second, the lesion site at the level
of the RPE was infiltrated by resident amoeboid Iba1+tomato+ rMG
and by Iba1+tomato recruited macrophages, likely of monocytic
origin as suggested by a loss of tomato in peripheral blood mono-
cytes. We next performed semi-automatic IMARIS-based image
quantification to assess the proportions and kinetics of different
myeloid cell subsets during CNV in the whole confocal stack volume
of single lesions (Fig 6D and E). In the retina, the percentage and
number of Iba1+tomato+ rMG were strongly increased during pathol-
ogy with minimal engraftment by peripheral monocytes while both
Iba1+tomato recruited macrophages and Iba1+tomato+ rMG were
present in the RPE (Fig 6D and E). To confirm a sufficiently high
recombination in rMG, we performed flow cytometry and found
virtually all CD45+CD11b+ rMG to be positive for tomato
(98.75  1.18%) after TAM treatment and only negligible tomato
expression in circulating CD45+CD11b+CD115+SScloLy6Chi (0.02 
0.02%) and CD45+CD11b+CD115+SScloLy6Clo (1.4  0.24%) mono-
cytes, suggesting specific and permanent labeling of long-lived
CX3CR1
+ macrophages in the eye (Boeck et al, 2020; Fig 6F). In addi-
tion, we would like to stress that TAM-independent recombination
events occur specifically in tomato reporter mice and were present in
around 50% of the CD45+CD11b+ rMG population, as reported before
(Chappel-Maor et al, 2020). However, peripheral blood monocytes
were not affected and consequently due to their short-lived nature
no interference with our experimental setup occured (Fig 6G). In
conclusion, we identified rMG emerging as the dominant myeloid
cell subset present during CNV formation.
Identification of myeloid subpopulations associated with
choroidal neovascularization
In order to analyze the diversity of myeloid cells on a single-cell
level during pathology, we induced CNV by laser treatment in
◀ Figure 3. Prenatal source of eye macrophages.
A Left: Creation of Acta1GFP/+:Acta1+/+ bone marrow chimeras. Right: Donor-derived GFP+CD45loCD11b+ were detectable in the recipient retina by flow cytometry
20 weeks after bone marrow reconstitution. FACS Plots are representative for five animals from one experiment.
B Quantification of GFP+ cells among CD45+CD11b+ retinal microglia by flow cytometry. Data are presented as mean  s.e.m. One symbol represents one mouse.
C Typical retinal flat mount from Acta1GFP/+:Acta1+/+ bone marrow chimeras 20 weeks after reconstitution. Donor-derived GFP+Iba1+ cells (arrow) and GFPIba1+
resident microglia (asterisks) are shown. Pictures are representative for three animals from one experiment. Scale bars represent 50 µm.
D Microscopy-based quantification of GFP+Iba1+ retinal microglia in the inner (IPL) and outer plexiform layer (OPL). One symbol represents one mouse. Data are
presented as mean  s.e.m.
E Scheme of a fate mapping experiment using Cx3cr1CreERT2:Rosa26-YFP female mice. Tamoxifen (TAM) and progesterone injection were performed at embryonic day 9.0
(E9.0). Mice were subsequently evaluated at postnatal day 0 (P0). Administration of TAM leads to intra-embryonic excision of a stop sequence flanked by loxP sites
(gray triangles) in Cx3cr1 expressing cells which causes stable and steady YFP expression under the control of the Rosa26 promotor.
F Direct fluorescence microscopic visualization for YFP (green), the macrophage marker Iba1 (red) and DAPI for the nuclei (blue) at P0. YFP+Iba1+ double-positive cells
are marked by arrows. YFPIba1+ single-positive cells are labeled by asterisks. Representative images out of five examined animals are shown. Scale bars represent
25 µm.
G Quantitative analysis of regional YFP expression in Iba1+ macrophages in TAM-induced and untreated Cx3cr1CreERT2:Rosa26-YFP mice. Bars represent means  s.e.m.
Quantification was done from three (untreated) or five (TAM) mice obtained from one (untreated) or two (TAM) independent experiments. Level of significance
determined by Mann–Whitney test between TAM and untreated revealed *P < 0.05 and Kruskal–Wallis test between retina, ciliary body, and cornea revealed
*P = 0.0204.
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8-week-old C57BL/6J mice and used non-lesioned littermates as
controls. We FACS-sorted CD45+CD3CD19Ly6G cell fractions of
the carefully excised central part of the retina enriched with lesioned
tissue at days 3 and 7 to perform scRNA-seq and compare it to
homeostatic retinal microglial cells (Figs 1 and 7A). Cytospins
revealed typical myeloid morphologies of isolated cells (Fig 7B).
Contaminating neuronal retinal cells were again excluded from
subsequent analysis (Fig EV5). Using the t-SNE algorithm (Fig 7C–
E), we visualized several clusters that were only present in the
CNV-related conditions (clusters 1, 7, 9, 10, 12, 13, 14) while others
(4 and 5) were mostly consisting of cells derived from the homeo-
static control time point d0 (Fig 7C).
Based on the expression of previously described cell type-
enriched gene expression signatures (Jord~ao et al, 2019), we identi-
fied microglia and dendritic cells (DC), as well as other myeloid cells
such as macrophages and peripheral blood-derived monocytes,
among all assigned cells (Fig 7D). Only few cells could not be
assigned to a certain cell type which represents a methodological
limitation due to transcriptionally similar (myeloid) cells (Fig 7D).
To clearly correlate the clusters to the control and diseased stages,
we performed hypergeometric testing and confirmed a significant
enrichment of cells derived from different conditions in specific
clusters (Fig 7F). Besides the clusters related to the control (cluster
4, 5), we identified several disease-associated clusters related to the
CNV d3 (cluster 1, 6, 7) and CNV d7 (cluster 11, 12, 14) time point
(Fig 7F). The contribution of the different (assigned) cell types to
the different stages showed the highest diversity at CNV d3 (Fig 7D
and G).
The clusters 4 and 5 were characterized by a high expression of
previously reported microglia signature genes, such as Hexb, C1qa,
and Sparc (Gautier et al, 2012; Butovsky et al, 2014; Fig 7H and I).
In contrast, cluster 6 was the only disease-associated rMG cluster
found to be exclusively associated with CNV d3 and showed a
“response to wounding” in the GO term analysis underlining its acti-
vated state (Fig EV6). In addition, this cluster shows a lower relative
abundance of expression of the microglia signature genes typically
expressed under homeostatic conditions, like Gpr34 and Csf1r, but a
relatively high expression of Gapdh suggesting an increased glyco-
lytic activity eventually due to local hypoxia (Fig 7H and I). The
heterogeneous expression pattern of Clusters 9 and 14 showed up-
regulated genes commonly expressed by both macrophages and
photoreceptor cells (Pdegb, Cnga1, Gnat1) indicating active phago-
cytosis of photoreceptor cell debris after laser coagulation (Fig 7H).
Despite the presence of photoreceptor cell-related genes, cluster 14
was assigned as macrophage, according to our cell type-enriched
gene expression signatures (Jord~ao et al, 2019) and expresses genes
included in the GO term “phagocytosis”, in addition to genes
involved in antigen presentation (H2-Aa, Cd74), interferon response
(Ifitm1, Ifitm3), and oxidative stress (Gpx1) (Figs 7H and I, and
EV6). DCs also expressed genes typical for antigen presentation
including Cd74 and H2-Aa, encoding MHC class II, but to a much
higher degree than macrophages (Fig 7H and I). In addition, the C-
type lectin Clec10a supports the DC identity of these cells besides
other genes (Fig 7I). The expression of Ly6c2, Plac8, and Ms4a4b
was only found in clusters consisting of lymphocytes, monocytes,
and granulocytes (Fig 7H and I). Taken together, our single-cell pro-
filing identified rMG and myeloid cell cluster associated with chor-
oidal neovascularization, suggesting that homeostatic subsets of
endogenous rMG are able to quickly change their phenotypes and
generate context- and time-dependent states. Notably, the novel
disease-associated rMG clusters were still transcriptional distinct
from cbMΦ and cMΦ.
Pseudotemporal ordering of the transcriptional dynamics during
the course of neovascularization
To gain more insights into the gradual transcriptional changes in
rMG during choroidal neovascularization, we performed a trajectory
analysis using Monocle. This enabled us to identify transcriptionally
different gene modules beyond the relative expression changes of
single signature genes across clusters. We set up the algorithm to
examine transcriptional changes between control, CNV d3, and CNV
d7 cells of the microglial and macrophage clusters 3, 4, 5, 6, 11, and
14 and identified three gene modules (Fig 8A). The first module was
enriched with control cells and characterized by the expression of
microglial genes, like Csf1r, Siglech, Tgfbr1, and Cx3cr1. The second
module was enriched with CNV d3 cells and characterized by the
expression of genes encoding proteins associated with cytoskeleton
◀ Figure 4. Contribution of definitive hematopoiesis to eye macrophage subsets during steady-state.
A Scheme of a fate mapping experiment using adult Cx3cr1CreERT2:Rosa26-YFP mice. Tamoxifen (TAM) injection was performed at postnatal day 42 (P42). Mice were
evaluated at 2, 12, and 24 weeks post-injections. Administration of TAM leads to the excision of a stop sequence flanked by loxP sites (gray triangles) in Cx3cr1
expressing cells in the eye which causes stable YFP expression under the control of the Rosa26 promotor.
B Flow cytometric measurement of the persistence of YFP+ retinal microglia (rMG), cliliary body (cb) MΦ, and corneal (c) MΦ in adult Cx3cr1CreERT2:Rosa26-YFP mice.
Doublets and dead cells were excluded by FSC-W and viability dye. Representative flow cytometry plots from two independent experiments with at least six mice are
displayed.
C Kinetics of YFP labeling in macrophages of the healthy eye. Symbols represent means  s.e.m. rMG are shown as squares (2 weeks: n = 10 mice, 12 weeks: n = 9
mice, 24 weeks: n = 12 mice, Kruskal–Wallis ns P > 0.05), cbMΦ are depicted as triangles (2 weeks: n = 4 samples from eight mice, 12 weeks: n = 3 samples from six
mice, 24 weeks: n = 6 samples from twelve mice, Kruskal–Wallis ns P > 0.05) and cMΦ as circles (2 weeks: n = 6 mice, 12 weeks: n = 8 mice, 24 weeks: n = 12 mice,
one-way ANOVA ***P < 0.0001). Data were obtained from two (cMΦ: 2 weeks, cbMΦ: 2 and 12 weeks), three (rMG: 2 weeks, cbMΦ: 24 weeks), or four (rMG: 12 and
24 weeks, coMΦ: 12 and 24 weeks) independent experiments.
D Sketch of the Flt3-dependent Cre-mediated recombination system with excision of the loxP-flanked stop-sequences leading to expression of YFP under the control of
the Rosa26 promotor in Flt3Cre:Rosa26-YFP mice.
E Left: Representative flow cytometric characterization of rMG by CD45 and CD11b and cbMΦ and cMΦ by CD45, CD11b, CD64, and F4/80 in Flt3Cre:Rosa26-YFP mice.
Doublets and dead cell were excluded. Right: representative flow cytometric images depicting YFP expression in eye tissue macrophages of 12- or 52-week-old Flt3Cre:
Rosa26-YFP mice. Typical images were taken from two independent experiments with six to seven mice.
F Quantification of the percentage of YFP+ eye macrophages at 12 and 52 weeks of age. rMG are shown as squares (12 weeks: n = 7 mice, 52 weeks: n = 6 mice), cbMΦ
as triangles (12 weeks: n = 3 samples from six mice, 52 weeks: n = 3 samples from six mice), and cMΦ as circles (12 weeks: n = 7 mice, 52 weeks: n = 6 mice). Data
are presented as means  s.e.m. and were acquired in two independent experiments.
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reorganization (Actb, Tuba1c, Tmsbx4) and proliferation (Ptma,
Pcna, Cdk1). The third module was enriched for CNV d7 cells, and
included genes underlying a more diverse regulation pattern, like
Sparc, and the genes Ctss, Cd74, and H2-Aa, typically expressed by
APC’s. As shown in the minimum spanning tree, CNV d3 repre-
sented the acute phase after lesion formation while CNV d7
consisted of cells expressing macrophage-associated genes and was
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decline in myeloid cell reactivity (Figs 8A and 7G). Despite the pres-
ence of diverse cell types in the CNV-lesioned areas, microglia repre-
sent the most abundant cell type at all investigated time points after
lesion formation (Figs 6D and E, and 7D and G).
Next, we took advantage of Cx3cr1CreERT2:Rosa26-tdTomato mice
to validate the down-regulation of P2RY12 and TMEM119 and the
presence of microglial proliferation indicated by the up-regulation of
the proliferating cell nuclear antigen (Pcna) and prothymosin
alpha (Ptma) (Fig 8B–D). Both P2ry12 and Tmem119 expression
decreased with disease progression and could only be detected in
the clusters 3, 4, and 5, but was lost in cluster 6 (Fig 8B and C). At
CNV d7, highly ramified tomato+P2RY12+ microglial cells were
found in non-lesioned area. However, inside and close to the
lesions, microglial morphology changed into a more heterogeneous
appearance. Here, beside tomato+P2RY12+ cells, we recognized
tomato+P2RY12lo microglia in the retina or almost undetectable
P2RY12 signals in tomato+ cells on the RPE (Fig 8B). Notably, the
protein expression pattern of TMEM119 strongly resembled P2RY12
having highly ramified tomato+TMEM119+ cells in unaffected
regions of the retina but a decrease of TMEM119 immunoreactivity
and ramification in tomato+ cells close to the lesion site in the same
retina and on the RPE corresponding to the lesion at CNV d7
(Fig 8C). In contrast, the increased expression of Pcna and Ptma
suggested enhanced proliferation during CNV. We confirmed this by
detecting EdU incorporation in tomato+Iba1+ rMG inside the lesion
at CNV d7 (Fig 8D).
Validation of murine disease-associated expression of MHC class
II in human neovascular CNV membranes
By comparing our findings in mice with the human situation, we
found that H2-Aa expression in CNV-lesioned mice mimicks the
expression in human CNV membranes of patients with neovascular
AMD, both on RNA and protein level (Fig 9A–D). In humans, CNV
membranes develop as newly formed fibrotic and vascularized
tissue underneath the RPE and were extracted during surgery. In the
murine retina, H2-Aa expression increased during the course of
CNV development (Fig 9A). In accordance with these findings,
MHC class II expression was absent in the retina distant to the
lesion but could be rarely found in the center of the lesion and only
very restricted to tomato+ rMGs which were surrounded by MHCII
cells (Fig 9B). By contrast, the diversity increased on the RPE where
we found tomato+MHCII+ more abundantly close to tomato+MHC
class II and also tomatoMHC class II+ cells that could represent
infiltrating cells (Fig 9B). The human CNV tissue was investigated
by a novel sequencing approach specifically tailored for formalin-
fixed and paraffin-embedded tissue (Boneva et al, 2020). The so-
called Massive Analysis of cDNA ends revealed a high expression of
HLA-DR, the human orthologous gene to the murine H2-Aa, specifi-
cally in the human CNV tissue but was almost absent in the controls
(Schlecht et al, 2020). We validated this finding by staining human
CNV and control tissue against HLA-DR. In the control, HLA-DR
was restricted to the choroid and absent in the retina but was more
abundantly expressed in the CNV membrane.
Taken together on gene and protein levels, we found time-depen-
dent progression from control to activated proliferating microglia
within 3 days following CNV induction. Furthermore, within 7 days
of CNV, microglia lost acute reactivity and adopted a macrophage-
like transcriptional profile. Thus microglia displayed a plastic,
context-dependent phenotype. Overall, our results suggest the emer-
gence of unique rMG states especially associated with CNV pathol-
ogy that are characterized by distinct signatures and contributing to
defined disease conditions.
Discussion
Our study provides a high-resolution view of the transcriptional
landscape of tissue macrophages across multiple compartments of
the eye and their distinct developmental pathways as well as their
different turnover kinetics during homeostasis. Using scRNA-Seq,
we identified several subsets of myeloid cells and their transcrip-
tional states in the cornea, ciliary body, and retina during health.
Some identified clusters showed a close relationship between home-
ostatic cbMΦ and cMΦ, while other clusters were significantly
enriched with either cbMΦ or cMΦ. By contrast, rMG were distinct
◀ Figure 5. Peripheral blood-derived origin of myeloid cells contributing to homeostatic turnover of eye macrophages.
A Left, Experimental setup of surgically connected parabiotic mice. Acta1GFP/+ and Acta1+/+ mice underwent parabiosis for 2, 12, and 20 weeks before analysis. Right,
quantification of GFP+Iba1+ microglia in the retina (rMG, squares, n.d. = not detectable), ciliary body (cbMΦ, triangles, Mann–Whitney ns P > 0.05), and cornea
(cMΦ, circles, Kruskal–Wallis **P = 0.0024) of parabiotic mice. Blood chimerism of CD45+CD11b+Ly6ChiGFP+ cells in the analyzed wild-type mice was 37.7  3.2%
(2 weeks), 27.5  2.7% (12 weeks), and 34.7  3.7% (20 weeks). Symbols represent mean  s.e.m. of three (2 weeks), four (12 weeks) or five (20 weeks) individual
mice. Scale bars represent 50 µm.
B–D Representative immunofluorescence images from the retina (20 weeks), ciliary body (12 weeks), and cornea (20 weeks) from flat mounts of Acta1+/+ parabiotic
mice. GFP+Iba1+ double-positive cells are marked by arrows, GFPIba1+ single-positive cells are labeled by asterisks and GFP+Iba1 leukocytes are indicated by
arrow heads. Pictures are representative of three animals.
E Flow cytometric quantification of RFP+ cells in Ccr2-RFP mice among CD45+CD11b+CD115Ly6Cint granulocytes (triangles, n = 4), CD45+CD11b+CD115+Ly6Clo
monocytes (filled squares, n = 4 mice), CD45+CD11b+CD115+Ly6Chi monocytes (open squares, n = 4 mice), CD45loCD11b+ rMG (squares, n = 6 mice),
CD45+CD11b+CD64+F4/80+ cbMΦ (triangles, n = 6 samples from 12 mice), and CD45+CD11b+CD64+F4/80+ cMΦ (filled circles, n = 12 mice, unpaired t-test
***P < 0.0001). Data were obtained from one (rMG) or two independent experiments (blood, cbMΦ, cMΦ). Data are presented as means  s.e.m.
F–H Flow cytometry of eye macrophages from healthy Ccr2RFP/+ mice (left) and representative histograms (right, Ccr2RFP/+ solid red line, Ccr2+/+ controls dotted
gray line).
I Flow cytometry of myeloid blood cells from Ccr2RFP/+ mice. Left: CD45+CD11b+ cells were further subdivided according to the expression of Ly6C and CD115 into
CD45+CD11b+CD115Ly6Cint granulocytes (gate 1), CD45+CD11b+CD115+Ly6Chi inflammatory (gate 2), and CD45+CD11b+CD115+Ly6Clo resident monocytes (gate 3),
respectively. Right: representative histograms are shown (Ccr2RFP/+ solid red line, Ccr2+/+ controls dotted gray line). Four mice were investigated.
J Top left, sketch of Ccr2-RFP construct. Top right, typical confocal picture for CCR2 (red), Iba1 (green), and collagen IV (Coll IV, white) revealing Ccr2-RFP expression
in a blood vessel (arrow, left image, scale bar represents 20 µm) and no RFP signal in retinal microglia (right images, scale bar represents 100 µm). Bottom,
representative pictures of the ciliary body and cornea immunolabeled with F4/80 (green), CCR2 (red), and DAPI (blue). Arrows indicate RFP+F4/80+ cells. Asterisks
point to RFPF4/80+ cells. Representative images from two independent experiments with three mice are displayed. Scale bars represents 20 µm.
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from both and transcriptionally different from myeloid cells found
in the steady-state cornea and ciliary body. By comparing all macro-
phages from the eye with the brain, rMG showed a close relation-
ship to microglia from the brain. Certain cluster were composed of
cells of all compartments, namely brain, retina, cornea, and ciliary
body underlining their close relationship. Notably, short-lived cMΦ
exhibited a molecular signature that was similar to BM-derived
monocytes and substantially different from rMG and bMG. In a
previous study, it was suggested to differentiate short- from long-
lived macrophages based on their differential clustering due to dif-
ferences in the expression of MHCII and CD11c (O’Koren et al,
2019). CMΦ were not further investigated in this study (O’Koren
et al, 2019). In our study, we detected cMΦ and few rMG to express
CD11c on protein level despite their long-lived nature but no MHC
class II protein which is in line with previous reports (Hamrah et al,
2003; Dando et al, 2016). Nevertheless, our findings revealed that
rMG and cbMΦ were transcriptionally unrelated to circulating
myeloid cells representing a new advancement in the field. In the
past, blood monocytes were thought to contribute to all of the three
investigated macrophage populations in the eye (Xu et al, 2007;
Kezic et al, 2008; Chinnery et al, 2008). These conclusions
were drawn based on results of irradiation studies, but this is
known today to compromise natural barriers when head shielding is
not applied.
The origin of tissue macrophages in different organs could be
traced back to erythromyeloid precursors in the yolk sac but the
origin of macrophages in the different compartments of the eye
remained unclear for a long time (Kierdorf et al, 2013a; Goldmann
et al, 2016; Hagemeyer et al, 2016; Ensan et al, 2016). Therefore, we
applied a conditional embryonic fate mapping model that allowed
us to follow yolk sac-derived macrophages in Cx3cr1CreERT2:Rosa26-
YFP mice until birth. Our results clearly showed a contribution of
embryonic precursors to rMG, cbMΦ, and cMΦ which was so far
only shown before for rMG (O’Koren et al, 2019). Of note, the
labeling efficiency in embryonic pulse labeling approaches is consis-
tently lower than conditional fate mapping in adult mice due to the
narrow time frame of developmental stages in the embryo (Gin-
houx et al, 2010; Perdiguero et al, 2014; Wieghofer & Prinz, 2015;
Goldmann et al, 2016; O’Koren et al, 2019). The relatively low
amount of prenatal labeling of cMΦ together with their transcrip-
tional profile resembling peripheral blood monocytes raised the
question about a possible steady turnover of these cells. Conse-
quently, we used adult Cx3cr1CreERT2:Rosa26-YFP mice to follow
the turnover of rMG, cbMΦ, and cMΦ for up to 24 weeks after YFP
induction. Beside the fact that rMG and cbMΦ remained stable
over time as shown before (O’Koren et al, 2019), cMΦ were the
only cell type that showed a steady and significant decrease of
YFP-expressing cells indicating a continuous replenishment. To
further validate our findings, we applied other models to exclu-
sively target bone marrow-derived peripheral blood leukocytes by
parabiosis and additionally used Flt3Cre:Rosa26-YFP mice to
broadly label myeloid cells of the definitive hematopoiesis (Boyer
et al, 2011). Again, cMΦ showed ongoing replenishment during
adulthood, revealed by the temporal increase of genetically labeled
partner-derived cells in wild-type parabionts and the highest
contribution of Flt3-dependent cells to this population. Of note,
our results obtained with parabiotic mice confirmed that cMΦ can
derive from circulating blood cells during adulthood, but do not
necessarily exclude a fetal liver origin.
In several CNS diseases, an infiltration of blood-derived mono-
cytes is occurring (Ajami et al, 2011; Ma et al, 2017; Ajami et al,
2018; Jord~ao et al, 2019). To distinguish rMG (tomato+) from infil-
trating monocytes (tomato) during pathology, we used
Cx3cr1CreERT2:Rosa26-tdTomato mice and investigated CNV that
mimics many aspects of neovascular AMD in humans. In this
model, lesions are formed in the choroid affecting the overlaid reti-
nal pigment epithelium (RPE) and the retina. Here, we found that
rMG constitute a major cell population in the diseased retina and
◀ Figure 6. Spatiotemporal characteristics of myeloid subsets during experimental neovascularization.
A Experimental setup. TAM was applied to 6-week-old Cx3cr1CreERT2:Rosa26-tdTomato mice leading to the excision of the stop sequence followed by robust Tomato
expression in microglia. At the age of 14 weeks (8 weeks post-TAM), three focal argon laser burns were applied to each retina to induce microglia activation and
subsequent choroidal neovascularization (CNV). Analysis was performed on days (d) 3, 7, 14, 28, and 56, respectively.
B Above: Representative funduscopic pictures from living healthy Cx3cr1CreERT2:Rosa26-tdTomato mice on d0. Funduscopy and red fluorescence visualize the fundus
and regular distribution of tomato+ microglia before the laser-induced lesion formation. Below: Corresponding immunofluorescence pictures. Non-lesioned retina
show a regular pattern of Iba1+ (green) tomato+ (red) retinal microglia while macrophages are absent on the retinal pigment epithelium (RPE) under native
conditions. Pictures are representative for six mice analyzed in one experiment. Scale bars represent 50 µm.
C Above: In vivo funduscopy on d7 post-lesion. Funduscopic and red fluorescence image depict the lesions (encircled with dashed white lines) and accumulation of
tomato+ microglia in Cx3cr1CreERT2:Rosa26-tdTomato mice. Intraperitoneal fluorescein application was performed to label retinal vessels and areas of choroidal
neovascularization. Below: Representative immunofluorescence for Iba1 (green) in Cx3cr1CreERT2:Rosa26-tdTomato mice. Resident retinal microglia are Iba1+tomato+
(asterisks) whereas blood-derived myeloid cells are Iba1+tomato (arrows) and accumulate at sites of laser-induced CNV. Overlay is shown left. Typical pictures
from six mice obtained from one independent experiment are shown. Scale bars represent 50 µm.
D Percentage (left) and absolute numbers (right) of myeloid subsets in the retina at different time points post lesion. Red columns, red lines, and red symbols
represent tomato+Iba1+ microglia in Cx3cr1CreERT2:Rosa26-tdTomato mice whereas green columns, green lines, and green symbols represent blood-derived
tomatoIba1+ myeloid cells. Left, Wilcoxon test at d3 (ns P = 0.0625), d28 (ns, P = 0.25), and d56 (ns P = 0.125) and paired t-test at d7 (***P < 0.0001), and d14
(***P < 0.0001; right, absolute numbers Kruskal–Wallis test (tomato+Iba1+ *P < 0.05, tomatoIba1+ **P < 0.01). Data represent means  s.e.m. from at least three
mice per group (two to six lesion per mouse) out of one (d0, d14, d28, d56) or two (d7, d14) independent experiments.
E Distribution (left) and absolute numbers (right) of myeloid cells in the RPE at different time points following laser-induced lesion. Red columns, red lines, and red
symbols represent tomato+Iba1+ microglia in Cx3cr1CreERT2:Rosa26-tdTomato mice. Green columns, green lines, and green symbols represent blood-derived
tomatoIba1+ myeloid cells. Left, paired t-test at d3, d7, d14 (**P < 0.01, ***P < 0.001), Wilcoxon test at d28 and d56 (ns P > 0.05); right, absolute numbers
Kruskal–Wallis test (ns P > 0.05). Data represent means  s.e.m. from at least three mice per group (two to six lesion per mouse) out of one (d0, d14, d28, d56) or
two (d7, d14) independent experiments.
F, G Flow cytometric measurement of tomato expression in 14-week-old Cx3cr1CreERT2:Rosa26-tdTomato mice 8 weeks after TAM treatment (F) or with no treatment (G).
Red lines represent the tomato signal and black lines the corresponding CreER-negative control. Data are presented as mean  s.e.m. from four mice analyzed in
one experiment.
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RPE with lower numbers of recruited monocytes. This finding is in
line with another model mimicking the advanced atrophic variant of
AMD by pharmacologically induced injury of the RPE and subse-
quent photoreceptor damage. Here, endogenous rMG were the most
abundant cell type in comparison with exogenously derived infiltrat-
ing monocytes (Ma et al, 2017).
Our single-cell profiling data provided further compelling
evidence that rMG responses to pathology are quite complex and
characterized by several disease-associated clusters of rMG. We
further identified a broad spectrum of non-rMG cell types that are
involved mainly consisting of DCs, lymphocytes, monocytes, and
macrophages. To gain more insight into the temporal gene signa-
ture changes across the myeloid cells, we performed a trajectory
analysis. Here, the highest diversity of cells was found at CNV
d3, the time point that clearly separated from the controls and
CNV d7 in the minimum spanning tree of the trajectory analysis.
Nevertheless, we found that disease model-associated rMG clus-
ters greatly differ from the rMG states found under homeostatic
conditions. The molecular signatures of the rMG clusters that
appeared during CNV were characterized by a down-regulation of
homeostatic genes, such as P2ry12 and Tmem119 which we could
confirm on protein level. In addition to other homeostatic micro-
glia signature genes that were dysregulated, like Siglech, Csf1r, or
C1qa, it is interesting to note that these were also down-regulated
in models of photoreceptor degeneration (O’Koren et al, 2019). At
the same time, other transcripts including Ptma and Pcna that are
associated with proliferation were increased. This is in line with
EdU incorporation in tomato+ rMG at CNV d7. In both, the CNV
model and under photoreceptor degeneration Spp1 and Lgals3
were up-regulated at later stages of the respective model. Finally,
we were able to correlate our findings in mice with the human
situation. Here, we confirmed that the increased expression of the
murine H2-Aa (MHC class II) in the experimental CNV model is
mirrored by the expression of the human counterpart HLA-DRA
that was increased in surgically extracted CNV membranes, both
on gene and protein level.
In conclusion, we identified several subsets of myeloid cells and
their transcriptional states in the cornea, ciliary body, and retina
during health by single-cell profiling. CbMΦ, cMΦ, and rMG all
showed a contribution from prenatal sources of primitive hemato-
poiesis but different dependences on bone marrow-derived cells
after birth leading to compartment-specific turnover rates of eye
macrophages. Our results will provide new insights into the biology
of myeloid subsets in the healthy and diseased eye that might open
new opportunities for the treatment of ophthalmological diseases
like AMD.
◀ Figure 7. Detection of disease-associated myeloid cell clusters.
A Schematic diagram depicting the experimental setup.
B Isolation of single myeloid cells from the retina under healthy conditions (d0) and three (d3) or 7 days (d7) after laser pulse for unbiased sampling and single-cell
RNA-seq (scRNA-seq). Increased cellular heterogeneity in lesioned mice compared with healthy controls (d0), shown by May-Gr€unwald-Giemsa stained cytospins.
Scale bars represents 10 µm.
C t-SNE representation of individual cells from all conditions analyzed (control represents homeostatic microglial cells), CNV d3, CNV d7, with scRNA-seq. Each dot
represents an individual cell. Color code indicates the different experimental conditions.
D t-SNE plot depicting different cell types.
E Unbiased cluster analysis of hematopoietic cell subpopulations found at different conditions.
F Marimekko chart showing the clusterwise distribution of 511 cells color-coded for the experimental conditions (control 122 cells, CNV d3 209 cells, CNV d7 180 cells).
Hypergeometric testing revealed significantly enriched clusters for the different conditions (control: cluster 4 and 5; CNV d3: cluster 1, 6 and 7; CNV d7: cluster 11, 12,
and 14), indicated by asterisks (*P < 0.05, **P < 0.01, ***P < 0.001).
G Marimekko chart presenting the proportion of cell types among all assigned cells (see Fig 5D) during different experimental conditions demonstrating almost pure
microglia populations present at d0, whereas clusters of dendritic cells (DC), lymphocytes, monocytes, granulocytes, and macrophages are present at d3 and d7 of
CNV.
H Heatmap of the 30 most regulated genes per cluster (adjusted P-value < 0.05 based on the negative binomial distribution). Asterisks highlight genes presented in t-
SNE plots shown in (I).The scale bar represents the color-coded z-scores.
I Selection of t-SNE plots representative for different cell subsets using Hexb, C1qa, and Sparc to show differential expression of these genes between microglia
subpopulations; Grp34, Csf1r, and Gapdh to depict cluster 6 as the highest activated microglia cluster; Cd74, H2-Aa, and Clec10a to present dendritic cell cluster;
Ly6c2, Plac8, and Ms4a4b to illustrate blood-derived cell cluster.
▸Figure 8. Disease stage-dependent gene expression pattern in myeloid cells during experimental CNV.A Trajectory analysis reveals alterations in gene expression pattern over time and disease state (d0, d3, d7). Above: Trajectory heatmap depicting loss of homeostatic
microglial gene expression signatures (P2ry12, Tmem119, Csf1r, SiglecH) and induction of genes involved in cytoskeleton modifications (Actb, Tuba1c), cell cycle
progression (Cdk1, Ptma), and antigen presentation (Cd74, H2-Aa). Highlighted molecules (asterisks) were confirmed by immunohistochemistry shown in (B–D). Below:
Trajectory plot showing the trajectory followed by myeloid cells upon CNV progress.
B Above: P2ry12 expression is shown by trajectory analysis and represented in a t-SNE plot. Expression is high in homeostatic microglia (see Figs 1G and H and 7H).
Below: Typical immunohistochemistry for P2RY12 (green) in unlesioned and lesioned areas. Arrows indicate lost P2RY12 expression. Asterisks mark microglial cells
that maintained P2RY12 expression. Iba1 immunohistochemistry (red) to show microglia. Pictures are representative of two mice. Scale bars represent 25 µm.
C Above: Tmem119 expression visualized by trajectory analysis and represented in a t-SNE plot. High signals in homeostatic microglia (see Fig 1G and H). Below:
TMEM119 immunofluorescence (green) by Iba1+ (red) microglia inside lesioned and non-lesioned areas in the retina and RPE. Arrows indicate microglia with lost
TMEM119 expression whereas asterisks mark microglial cells that maintained TMEM119 expression. Picture is representative of two mice. Scale bars represent 25 µm.
D Above: Ptma expression presented by a t-SNE plot and its trajectory analysis over the disease course. Ptma expression correlates with proliferation of rMGs at d7
during CNV in Cx3cr1CreERT2:Rosa26-tdTomato mice. Below: Representative immunofluorescence of proliferating EdU+ (white) Iba1+ (red, Tomato) microglia at sites of
CNV on d7 (arrow) next to an EdUTomato+Iba1 cell (asterisks) after EdU treatment from d0 to d6. Arrowhead points toward an intravascular myeloid
EdUTomatoIba1+ cell. Typical pictures from three mice obtained from one independent experiment are shown. Scale bar represents 25 µm.
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◀ Figure 9. Correlative analysis between murine experimental and human neovascular CNV.
A H2-Aa expression visualized by trajectory analysis and represented in a t-SNE plot.
B H2-Aa immunohistochemistry (green) by Iba1+ (red) microglia inside lesioned and non-lesioned areas in the retina and RPE. Arrows indicate microglia with acquired
MHCII expression whereas asterisks mark microglial cells that remained MHCII negative. Picture is representative of two mice. In the RPE, arrow heads label
TomMHCII+ cells. Scale bars represent 25 µm.
C HLA-DRA mRNA expression examined by RNA-Seq via Massive analysis of cDNA ends (MACE) analysis of human formalin-fixed and paraffin-embedded (FFPE)
membranes of choroidal neovascularization (CNV). Bars represent means  s.e.m. of four investigated human samples of age-related macular degeneration
associated with choroidal neovascularization and four control tissues consisting of choroid and RPE. Level of significance was calculated using DESeq
(P = 3.61 × 1021).
D Immunohistochemistry for HLA-DR in the RPE/choroid of one control and the CNV membrane of one patient suffering from age-related macular degeneration
associated with choroidal neovascularization.
Materials and Methods
Reagents and Tools table
Reagent/Resource Reference or Source
Identifier or Catalog
Number
Acta1GFP/+ CMV–b-actin hybrid promoter, Ajami et al 2007
Ccr2RFP/+ B6.129(Cg)-Ccr2tm2.1Ifc/J (Stock No: 017586, JAX mice)
Cx3cr1GFP/+ B6.129P2(Cg)-Cx3cr1tm1Litt/J (Stock No: 005582)
Cx3cr1CreERT2 B6.129P2(C)-Cx3cr1tm2.1(cre/ERT2)Jung/J (Stock No: 020940)
Flt3-Cre Benz et al 2008
HexbtdT/tdT Masuda et al 2020
Itgax-DTR/EGFP B6.FVB-1700016L21RikTg(Itgax-DTR/EGFP)57Lan/J (Stock No.
004509, JAX mice)
Rosa26-fl-stop-fl-tdTomato B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J ( Stock No:
007909, JAX mice)
Rosa26-fl-stop-fl-EYFP B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J (Stock No: 006148,
JAX mice)
Antibodies
rabbit anti-Iba-1, polyclonal, 1:500 (cryo) or 1:1000 (flat-mount) WAKO, Osaka, Japan cat # 019-19741
rabbit anti-Iba-1, polyclonal, 1:500 (cryo) or 1:1000 (flat-mount) Synaptic Systems, G€ottingen, Germany cat # 234 013
rabbit anti-P2RY12, polyclonal, 1:500 AnaSpec, Fremont, USA cat # AS-55043A
rabbit anti-Tmem119, polyclonal, 1:500 Synaptic Systems, G€ottingen, Germany cat # 400 002
rat anti-MHC class II (clone M5.114.15.2), monoclonal, 1:500 BioLegend, USA cat # 107602
goat anti-GFP, polyclonal, 1:1000 Rockland Immunochemicals Inc., Gilbertsville, USA cat # 600-106-215
goat anti-GFP, polyclonal, 1:1000 Acris Antibodies Inc., San Diego, USA cat # R1091P
rat anti-CD74-Alexa Flour® 647 (clone In1/CD74), monoclonal, 1:100 BioLegend, USA cat # 151003
rat anti-CD206-Alexa Flour® 647 (clone MR5D3), monoclonal, 1:100 Bio-Rad Laboratories, UK cat # MCA2235A647
rat anti-F4/80 (clone BM8), monoclonal, 1:100 Abcam plc., UK cat# ab16911
donkey anti-rabbit, Alexa Fluor 568®, polyclonal, 1:500 Thermo Fisher Scientific Inc., USA cat # A10042
donkey anti-goat Alexa Fluor 647®, polyclonal, 1:500 Thermo Fisher Scientific Inc., USA cat # A-21447
goat anti-rabbit, Alexa Fluor 647®, polyclonal, 1:500 Thermo Fisher Scientific Inc., USA cat # A-21244
goat anti-rat, Alexa Fluor 568®, polyclonal, 1:500 Thermo Fisher Scientific Inc., USA cat # A-11077
goat anti-rat, Alexa Fluor 647®, polyclonal, 1:500 Thermo Fisher Scientific Inc., USA cat # A-21247
mouse anti-HLA-DP, DQ, DR, (clone CR3/43), monoclonal, 1:200 Agilent Dako, Santa Clara, CA, USA) cat # M0775
Fc receptor blocking antibody CD16/CD32 (clone 2.4G2) BD Pharmingen, BD Biosciences, Heidelberg, Germany cat # 553141
rat anti-CD11b-BV421 (clone M1/70), monoclonal, 1:100 BioLegend, USA cat # 101235
rat anti-CD45-APC-e780 (clone 30-F11), monoclonal, 1:100 Thermo Fisher Scientific Inc., USA cat # 47-0451-82
rat anti-CD115-PE-Cy7 (AFS98), monoclonal, 1:100 Thermo Fisher Scientific Inc., USA cat # 25-1152-82
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Reagents and Tools table (continued)
Reagent/Resource Reference or Source
Identifier or Catalog
Number
rat anti-F4/80-PE-Cy7 (BM8), monoclonal, 1:100 Thermo Fisher Scientific Inc., USA cat # 25-4801-82
mouse anti-CD64-Alexa647 (clone, X54-5/7.1), monoclonal, 1:100 BioLegend, USA cat # 139322
rat anti-Ly6C-FITC (clone AL-21), monoclonal, 1:100 BD Pharmingen, BD Biosciences, Heidelberg, Germany cat # 553104
rat anti-Ly6G-PE-Cy7 (clone 1A8), monoclonal, 1:100 BD Pharmingen, BD Biosciences, Heidelberg, Germany cat # 560601
anti-CD45-BV421 (clone 30-F11), monoclonal, 1:100 BioLegend, USA cat # 103134
rat anti-CD3-PE-Cy7 (clone 17A2), monoclonal, 1:100 BioLegend, USA cat # 100220
rat anti-CD19-PE-Cy7 (clone 6D5), monoclonal, 1:100 BioLegend, USA cat # 115519
Oligonucleotides and other sequence-based reagents
RNAprotect Tissue Reagent QIAGEN, Hilden, Germany cat # 76104
RNeasy Plus Micro Kit QIAGEN, Hilden, Germany cat # 74034
Buffer RLT Plus QIAGEN, Hilden, Germany cat # 1053393
SMARTer Ultra Low Input RNA Kit for Sequencing v4 Clontech Laboratories, Inc., Mountain View, CA, USA cat # 634456
KAPA SYBR FAST ABI Prism Library Quantification Kit Roche, Basel, Switzerland cat # KK4835
Illumina TruSeq SR Cluster Kit v3 Illumina, USA cat # GD-401-3001
TruSeq SBS v3 Reagents Illumina, USA cat # FC-401-3001
AMPure/RNAClean XP beads Beckman Coulter, M€unchen, Germany cat # A63987
Quick-RNA FFPE Kit Zymo Research, USA cat # R1008
DNAse I digestion using the Baseline-ZERO kit Lucigen Corporation, USA cat # DB0715K
Qubit RNA HS Assay Kit Thermo Fisher Scientific Inc., USA cat # Q32852
RNA Pico Sensitivity Assay Perkin Elmer, USA cat # CLS960012
Chemicals, enzymes and other reagents
Fluorescein Alcon Pharma GmbH cat # H12588-0113
Tissue-Tek® O.C.T.TM Compound Sakura Finetek Germany GmbH cat # 4583
in Vitro-Clud® (R. Langenbrinck GmbH, Emmendingen, Germany). R. Langenbrinck GmbH, Emmendingen, Germany cat # 04-0001
May-Gr€unwald (Merck 101424) Merck cat # 101424
Giemsa (Merck 109204) Merck cat # 109204
Tamoxifen (TAM, T5648-1G, Sigma-Aldrich, Taufkirchen, Germany) Sigma-Aldrich, Taufkirchen, Germany cat # T5648-1G
corn oil (Sigma-Aldrich, C8267-500ml) Sigma-Aldrich, Taufkirchen, Germany cat # C8267-500ml
Hank’s Balanced Salt Solution Thermo Fisher Scientific Inc., USA cat # 14170138
eBioscienceTM Fixable Viability Dye eFluorTM 506 Thermo Fisher Scientific Inc., USA cat # 65-0866-14
eBioscienceTM Fixable Viability Dye eFluorTM 780 Thermo Fisher Scientific Inc., USA cat # 65-0865-18
Software
FACSDiva software BD Biosciences, Heidelberg, Germany
FlowJo software (7.6.1) Treestar (BD Biosciences, Heidelberg, Germany)
IMARIS 8.0 Bitplane, Switzerland
FV10-ASW 4.2 Viewer Olympus, Tokyo, Japan
GraphPad Prism (Version 6.0) GraphPad Software, USA
Other
RS 2000 Biologica x-Ray irradiator Rad Source Technologies, USA
VISULAS 532s Carl Zeiss Meditec AG, Jena, Deutschland
Olympus BX-61 fluorescence microscope Olympus, Tokyo, Japan
Olympus DP71 color camera Olympus, Tokyo, Japan
BZ-9000 fluorescence microscope Keyence, Osaka, Japan
Fluoview FV 1000 confocal microscope Olympus, Tokyo, Japan
20x 0.95 NA XLUMPlanFL N objective Olympus, Tokyo, Japan
20 of 27 The EMBO Journal 40: e105123 | 2021 ª 2021 The Authors
The EMBO Journal Peter Wieghofer et al
Reagents and Tools table (continued)
Reagent/Resource Reference or Source
Identifier or Catalog
Number
20x 0.75 NA U Plan S Apo objective Olympus, Tokyo, Japan
40x 0.95 NA U Plan S Apo objective Olympus, Tokyo, Japan
DMi-8 confocal microscope Leica, Wetzlar, Germany
20x NA 0.75 CS2 objective Leica, Wetzlar, Germany
FACSCanto II BD Biosciences, Heidelberg, Germany
FACSAria III BD Biosciences, Heidelberg, Germany
MoFlo High Speed Cell Sorter Beckman Coulter, M€unchen, Germany
HiSeq 3000 Illumina, USA
HiSeq 1000 Illumina, USA
NextSeq 500 Illumina, USA
mosquito® HTS Nanolitre Liquid Handler SPT Labtech, USA
Autostainer Agilent Dako, Santa Clara, CA, USA
Qubit Fluorometer Life Technologies, USA
LabChip GXII Touch Perkin Elmer, USA
384-well plates Biorad, Munich, Germany
RNeasy Plus Micro Kit QIAGEN, Hilden, Germany cat # 74034
Click-iT® EdU Alexa Fluor® 488 Imaging Kit Thermo Fisher Scientific cat # C10337
Dako REALTM EnVisionTM Detection System Kit Agilent Dako, Santa Clara, CA, USA cat # K406511-2
Methods and Protocols
Mice
In this study, C57BL/6J mice were used as wild-type (WT) mice. All
transgenic lines (Acta1GFP/+, Ccr2RFP/+, Cx3cr1GFP/+, HexbtdT/tdT,
Cx3cr1CreERT2, Flt3Cre, Rosa26-fl-stop-fl-EYFP (Rosa26-YFP), and
Rosa26-fl-stop-fl-tdTomato (Rosa26-tdTomato)) were bred on a
C57BL/6J background under specific pathogen-free conditions and
devoid of Crb1 (RD8) mutations. Itgax-DTR/EGFP (CD11c-GFP)
mice were purchased from Jackson Laboratory (Stock No. 004509,
C57BL/6J background). Cx3cr1CreERT2 were crossed to Rosa26-YFP
or Rosa26-tdTomato. Flt3Cre were crossed to Rosa26-YFP. All animal
experiments were approved by local administration and were
performed in accordance with the respective national, federal, and
institutional regulations.
Tamoxifen treatment
For induction of the nuclear CreER-T2 recombinase activity in adult
animals, 6- to 8-week-old Cx3cr1CreERT2 mice of mixed gender were
treated with 4 mg Tamoxifen (TAM, T5648-1G, Sigma-Aldrich, Tauf-
kirchen, Germany) dissolved in 200 µl corn oil (Sigma-Aldrich, C8267-
500ml) and injected subcutaneously at two time points 48 h apart. For
pulse labeling experiments, the CreER-T2 recombinase activity was
induced in Cx3cr1CreERT2:Rosa26-YFP embryos with 200 µl of 20 mg/
ml TAM and 10 mg/ml Progesterone dissolved in corn oil by i.p. injec-
tions into pregnant females at 9 days post-coitum.
BM transplantation
Eight-week-old recipient wild-type mice were irradiated and recon-
stituted with 5 × 106 bone marrow cells derived from femur and
tibia of an adult donor (Acta1GFP/+) mice, injected into the tail vein
of recipients. Mice received whole-body irradiation (11 Gy) 24 h
prior to bone marrow reconstitution with an RS 2000 Biologica x-
Ray irradiator. After 4 weeks, reconstitution efficiency in the
blood was assessed by flow cytometry and found to be > 90% in
Ly6Chi monocytes.
Parabiosis
Pairs of female WT and Acta1GFP/+ mice were surgically connected
for 2, 12, and 20 weeks as previously described (Ajami et al, 2007).
Blood sharing was verified between 10 and 15 days after surgery
and at the day of dissection by flow cytometry (see below).
After transcardial perfusion with PBS, eyes were fixed in 4%
paraformaldehyde (PFA, wt/vol) for 1 h at RT and flat-mounted
after free-floating immunofluorescence staining of the retina
(see below).
Laser-induced choroidal neovascularization model
Mice of mixed gender that underwent induction of choroidal neovas-
cularization (Tobe et al, 1998) were anesthetized with a mixture of
ketamine (100 mg/kg) and xylazine (6 mg/kg), and pupils were
dilated with a combination of 0.5% tropicamide and neosynephrine-
POS 5%. Corneal gel was applied to maintain hydration of the
cornea and reduce media opacifications. Mice were placed in front of
an argon laser (VISULAS 532s, ZEISS) after the pupils were comple-
tely dilated. A cover slip with a drop of gel was placed on the eye as
a contact lens to convert the curved cornea surface to a planar
surface. Three laser burns at equal distance from the optic disk were
induced by an Argon laser with a wavelength of 532 nm, a power of
150 mW, a fixed diameter of 100 µm, and duration of 100 ms. Only
burns that produced a bubble as a sign for retinal pigment epithelial
rupture were included in the study. After laser treatment, mice were
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then placed on a pre-warmed warming plate at 35°C until they recov-
ered from anesthesia. Fundus imaging and fluorescence angiography
was performed by injecting 40 µl Fluorescein (ALCON 10%, H12588-
0113) diluted 1:20 with 0.9% NaCl per 20 g mouse. At the respective
days after laser treatment (d3, d7), mice were transcardially perfused
with PBS, eyes were fixed in 4% paraformaldehyde (PFA, wt/vol)
for 1 h at RT and flat-mounted after free-floating immunofluores-
cence staining of the retina (see below).
Fluorescence microscopy
After transcardial perfusion with phosphate-buffered saline (PBS),
eyes were fixed in 4% PFA for 1 h at RT and processed as previ-
ously described for flat mounts (Pitulescu et al, 2010) or dehydrated
in 30% sucrose and embedded in Tissue-Tek O.C.T.TM Compound
(Sakura Finetek Germany GmbH) for cryosections. In brief, eye cups
were dehydrated in 30% sucrose after fixation and embedded in
Tissue-Tek. 12 µm sections were then blocked with PBS containing
5% bovine serum albumin and permeabilized with 0.1% Triton X-
100 in blocking solution. Primary antibodies were added over night
at a dilution of 1:500 (cryo) or 1:1,000 (flat mount) for Iba-1 (019-
19741, WAKO, Osaka, Japan; 234 013, Synaptic Systems, G€ottingen,
Germany), 1:500 for P2RY12 (AS-55043A, AnaSpec, Fremont, USA),
Tmem119 (400 002, Synaptic Systems, G€ottingen, Germany) and
MHC class II (clone M5.114.15.2, 107602, BioLegend) and 1:1,000
for anti-GFP (600-106-215, Rockland Immunochemicals Inc.,
Gilbertsville, USA; R1091P, Acris Antibodies Inc., San Diego, USA),
1:100 for CD74-Alexa Flour 647 (clone In1/CD74, 151003, BioLe-
gend, USA), and CD206-Alexa Flour 647 (clone MR5D3,
MCA2235A647, Bio-Rad Laboratories, UK) at 4°C. Secondary anti-
bodies were added in a dilution of 1:500 (Alexa Fluor 568 and
Alexa Fluor 647, Thermo Fisher Scientific, Waltham, USA) for 2 h
at RT (cryo) or overnight at 4°C (flat mount). Nuclei were counter-
stained with 40,6-Diamidin-2-phenylindol (DAPI). Images were
taken using a conventional fluorescence microscope (Olympus BX-
61 with a color camera (Olympus DP71)) (Olympus, Tokyo, Japan)
or BZ-9000 (Keyence, Osaka, Japan), and the confocal pictures were
taken with a Fluoview FV 1000 (Olympus) using a 20x 0.95 NA
XLUMPlanFL N, 20x 0.75 NA U Plan S Apo, or a 40x 0.95 NA U Plan
S Apo or a DMi-8 (Leica) with a 20x NA 0.75 CS2 (Leica 506517).
Cytospin
After sorting of the cells for scRNA-seq, the same tube was further
sorted in another tube containing 500 µl of HBSS and heat-inacti-
vated fetal calf serum (1:1) and kept on ice until centrifugation.
Samples were transferred to centrifugation tubes and centrifuged at
64 g for 5 min. Next samples were transferred to a specific
cytochamber system (Hettich Instruments, Tuttlingen, Germany)
and centrifuged for 5 min at 36 g; supernatant was removed
followed by a drying centrifugation step (3 min, 122 g) and subse-
quent cell staining. Prior to the staining, May-Gr€unwald (Merck
101424) and the diluted Giemsa (Merck 109204) solutions have to
be prepared freshly, filtered before use, and were applied at RT. Air-
dried slide with spinned down cells underwent a 4-min incubation
in May-Gr€unwald solution (Merck 1.01424). After that, the solution
is diluted by adding an equal volume of aqua bidest for another
4 min. Next, the diluted May-Gr€unwald solution was discarded and
the slides were rinsed with aqua bidest. The Giemsa staining has to
be incubated for 15 min at a dilution of 1:10 in aqua bidest and
washed off with aqua bidest before a brief incubation in 100%
ethanol followed by xylol before embedding.
In vivo EdU proliferation assay
Eight weeks following TAM injection Cx3cr1CreERT2:Rosa26-tdTo-
mato mice underwent laser treatment to induce choroidal neovascu-
larizations (d0). EdU (100 µg/day) was applied intraperitoneally
from day 0 to day 6 once daily. Mice were sacrificed at day 7. EdU
was visualized by the Click-iT EdU Alexa Fluor 488 Imaging Kit
(Thermo Fisher Scientific, C10337) according to the manufacturers
protocol, nuclei by DAPI and myeloid cells by anti-Iba1 and
secondary anti-rabbit Alexa Fluor 647 antibody.
Identification of microglia and circulation-derived monocytes
Cx3cr1CreERT2:Rosa26-tdTomato mice of mixed gender were lasered
8 weeks after TAM treatment to induce choroidal neovasculariza-
tion. After perfusion with PBS at the indicated time points following
laser treatment, retinal and RPE/choroidal whole-mounts were
fixed, stained, and flat-mounted. The lesions were imaged on a
Fluoview FV1000 (see above). Iba1+ cells were identified in the
stack volume using IMARIS and automatically classified as
Iba1+tom+ microglia or Iba1+tom periphery-derived monocytes,
according to the calculated stack-specific background in the tomato
channel. The percentage of tomato+/ was determined among all
Iba1+ cells in the whole lesioned stack volume imaged at a 20×
magnification.
Flow cytometry
Eyecups were carefully dissected under a binocular to separate
retina, cornea and ciliary body. Monocytes were isolated from
bone marrow. Cornea and ciliary body tissues were separated into
single-cell suspensions by Collagenase D digestion, resuspension,
and filtration through 70 µm cell sieve. Retina was dissociated by
resuspension. Two mice were pooled for ciliary body samples if
not indicated differently. Dead cell exclusion was performed by
incubation with fixable viability dye 506 or 780 (eBioscience),
respectively. Anti-CD16/CD32 Fc block was performed to avoid
unspecific binding. Cells were stained with primary antibodies
directed against CD11b (M1/70), CD45 (30-F11), CD115 (AFS98),
F4/80 (BM8) (eBioscience), CD64 (X54-5/7.1), Ly6C (AL-21), and
Ly6G (1A8) at 4°C for 20 min at a concentration of 1:200 if not
indicated differently. CD206 (C068C2) (BioLegend) was incubated
at 4°C for 45 min. Cells were washed and analyzed using a FACS-
Canto II or a FACSAria III (RFP detection in Ccr2RFP/+ mice) (BD
Biosciences, Heidelberg, Germany). Sorting was performed using a
MoFlo High Speed Cell Sorter (Beckman Coulter, M€unchen). Data
were acquired with FACSDiva software (Becton Dickinson).
Postacquisition analysis was performed using FlowJo software.
(Gating strategy: Fig EV6).
RNA sequencing and analysis
C57BL/6J mice negative for the RD8 mutation were purchased from
Charles River and analyzed at the age of 8 weeks. Total bulk RNA
was extracted from directly into RNAprotect buffer (QIAGEN,
Hilden, Germany) FACS-sorted CD45+CD11b+Ly6CLy6G retinal
and brain microglia, CD45+CD11b+CD64+F4/80+Ly6CLy6G cornea
macrophages and CD45+CD11b+SScloCD115+Ly6Chi BM monocytes,
according to the “Purification of total RNA from animal and human
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cells” protocol of the RNeasy Plus Micro Kit (QIAGEN). In brief,
cells were stored and shipped in RNAprotect buffer at 2–8°C. After
pelleting, the RNAprotect buffer was replaced by RLT Plus buffer
(QIAGEN) and the samples were homogenized by vortexing for
30 s. Genomic DNA contamination was removed using gDNA Elimi-
nator spin columns. Next ethanol was added and the samples were
applied to RNeasy MinElute spin columns followed by several wash
steps. Finally, total RNA was eluted in 12 ll of nuclease free water.
Purity and integrity of the RNA were assessed on the Agilent 2100
Bioanalyzer with the RNA 6000 Pico LabChip reagent set (Agilent,
Palo Alto, CA, USA).
The SMARTer Ultra Low Input RNA Kit for Sequencing v4 (Clon-
tech Laboratories, Inc., Mountain View, CA, USA) was used to
generate first strand cDNA from 150 to 600 pg total RNA. Double-
stranded cDNA was amplified by LD PCR (12–14 cycles) and puri-
fied via magnetic bead cleanup. Library preparation was carried out
as described in the Illumina Nextera XT Sample Preparation Guide
(Illumina, Inc., San Diego, CA, USA). 150 pg of input cDNA were
tagmented (tagged and fragmented) by the Nextera XT transpo-
some. The products were purified and amplified via a limited-cycle
PCR program to generate multiplexed sequencing libraries. For the
PCR step, 1:5 dilutions of index 1 (i7) and index 2 (i5) primers
were used. The libraries were quantified using the KAPA SYBR
FAST ABI Prism Library Quantification Kit (Kapa Biosystems, Inc.,
Woburn, MA, USA). Equimolar amounts of each library were
pooled, and the pools were used for cluster generation on the cBot
with the Illumina TruSeq SR Cluster Kit v3. The sequencing run
was performed on a HiSeq 1000 instrument using the indexed, 50
cycles single-read (SR) protocol, and the TruSeq SBS v3 Reagents
according to the Illumina HiSeq 1000 System User Guide. Image
analysis and base calling resulted in .bcl files, which were
converted into .fastq files with the bcl2fastq v2.18 software. RNA
extraction, library preparation, and RNA-seq were performed at the
Genomics Core Facility “KFB—Center of Excellence for Fluorescent
Bioanalytics” (University of Regensburg, Regensburg, Germany).
Differential Gene Expression Analysis and Data Visualization: Fastq
files were quality controlled using FastQC (Andrews, 2010) and FastQ
Screen (Winget, 2011) software. Raw data were then mapped to the
mouse genome (Gencode version M11 (Mudge & Harrow, 2015)) using
the STAR 2.5.2b aligner (Dobin et al, 2013). Subsequently aligned
reads were matched with transcriptome annotation, and gene counts
were generated using featureCounts 1.5.1 (Liao et al, 2014). Read
count normalization and differentially gene expression analysis was
performed using the limma/voom pipeline (limma 3.34.0) (Law et al,
2014). Data visualization was performed using the gplots and ggplot2
packages in R. Spider Plots: Log2fold changes vs. brain microglia were
calculated through limma/voom for retinal microglia, cornea macro-
phages, and bone marrow monocytes (Warnes et al, 2016). This three-
dimensional dataset was subsequently projected into two dimensions
as previously described van de Laar et al, 2016). Briefly x0 and y0
dimensions were calculated as X0 = cos(0°)*X + cos(120°)*Y + cos
(240°)*Z and Y0 = sin(0°)*X + sin(120°)*Y + sin(240°)*Z with X =
coMacvsbMG, Y = BM-MovsbMG, and Z = rMGvsbMG. Visualization
was performed using ggplot2.
Single-cell RNA sequencing
C57BL/6J female mice devoid of the RD8 mutation were purchased
by Charles River and analyzed at the age of 8 weeks. After perfusion
with PBS and careful dissection of retina, ciliary body, and cornea
under a binocular, viable CD45+CD3CD19Ly6G cells from each
compartment (retina, ciliary body and cornea) were pooled from
five individual mice prior to flow cytometry-based purification into
384-well plates (Bio-Rad, Munich, Germany) (see “flow cytometry”
above) in two independent experiments. The data from these mice
were used as control for the CNV experiments. For CNV experi-
ments, C57BL/6J female mice underwent laser-induced choroidal
neovascularization (see above). At CNV d3 and d7, lesioned central
retina from ten eyes out of seven (d3) or eight (d7) mice was cut
out, processed for flow cytometry, and pooled per condition prior to
purify viable CD45+CD3CD19Ly6G cells into 384-well plates.
Five non-lesioned C57BL/6J mice served as controls. The used anti-
bodies were CD45-BV421 (30F-11, cat# 103134), CD3-PE-Cy7 (17A2,
cat# 100220), and CD19-PE-Cy7 (6D5, cat# 115519) from BioLegend
and Ly6G-PE-Cy7 (1A8, cat# 560601, BD Biosciences). Before and
after sorting, the 384-well plate were centrifuged for 2 min at 845 g
4°C. Subsequently, sorted plates were snap-frozen in liquid nitrogen
and stored at 80°C until RNA extraction. Single-cell RNA sequenc-
ing was performed using CEL-Seq2 method (Hashimshony et al,
2016) with several modifications as previously described (Herman
et al, 2018). A fivefold volume reduction was achieved using a
nanoliter-scale pipetting robot (Mosquito HTS, TTP Labtech). 160 nl
of reverse transcription reaction mix and 2.2 ll of second strand
reaction mix was used to convert RNA into cDNA. cDNA were
pooled before cleanup and in vitro transcription, generating two
libraries from one 384-well plate containing the barcodes 1–192. For
cleanup, AMPure/RNAClean XP beads (Beckman Coulter) were
used at a beads-to-sample ratio of 0.8:1. Other steps were performed
as described in the original protocol. 18 libraries (1,536 single cells)
were sequenced per lane (pair-end multiplexing run, 100 bp read
length) of an Illumina HiSeq 3000 sequencing system at a depth of
~ 130,000–200,000 reads per cell. Paired-end reads were aligned to
the transcriptome using bwa (version 0.6.2-r126) with default
parameters Li & Durbin, 2010). The transcriptome contained all
RefSeq gene models based on the mouse ENCODE VM9 release
downloaded from the UCSC genome browser comprising 57,207
isoforms with 57,114 isoforms mapping to fully annotated chromo-
somes (1–19, X, Y, M). All isoforms of the same gene were merged
to a single gene locus and gene loci that overlap of > 75% were
merged to gene groups resulting in 34,111 gene groups. The 50 bp
of the right mate of each read pair were mapped to the ensemble of
all genes and to 92 ERCC spike-ins in sense direction (Baker et al,
2005). Only uniquely mapped reads were retained. The left read
contained the barcode information: the first six bases corresponded
to the unique molecular identifier (UMI) followed by six bases
representing the cell-specific barcode. The remainder of the left read
contained a polyT stretch. The left read was omitted from quan-
tification. For each cell barcode, the number of UMIs per transcript
was counted and aggregated across all transcripts derived from the
same gene locus. Based on the binomial distribution, the number of
observed UMIs was converted into transcript counts (Gr€un et al,
2014). The number of quantified genes was 21,129 for laser-induced
choroidal neovascularization and 21,427 genes for the comparison
between macrophage populations. Identification and visualization
of different subpopulations as well as differential gene expression
analysis was performed with the RaceID3 algorithm version 0.1.5
(Herman et al, 2018). All samples were processed on the same day.
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Mitochondrial genes were excluded prior to analysis. Down-scaling
to 1,000 transcripts was used for data normalization, and cells with
< 1,500 transcripts were discarded. Furthermore, cells expressing
> 2% of Kcnq1ot1, a potential marker for low-quality cells (Gr€un
et al, 2016), were excluded from analysis. RaceID3 analysis was
performed with the following parameters: mintotal = 1,000,
minexpr = 5, outminc = 5, FSelect = TRUE, and probthr = 108.
Differentially expressed genes were identified similar to the DESeq2
algorithm (Anders & Huber, 2010).
Clusterwise enrichment analysis of cells from the respective
anatomical locations or treatments was conducted using hypergeo-
metric testing. Here, the number of cells per cluster per condition
and the total number of cells per condition were taken into account.
Statistical testing was achieved using the phyper function in R for
the probability to assess the probability that n or more cells from a
given condition are found per cluster by chance.
Trajectory analysis to assess stepwise changes of cell states was
performed using Monocle version 2.99.319. Default parameters were
applied besides the following adjustments: genes expressed in n ≥ 3
cells with a mean expression of ≥ 0.5; in the newCellDataSet func-
tion  lowerDetectionLimit = 0.5; in the detectGenes function 
min_expr = 0.5; in the reduceDimensions function  max_compo-
nents = 2, num_dim = 6, reduction_method=”tSNE”; in the clusterCells
function  num_clusters = 11; for the plot_pseudotime_heatmap
function differentially expressed genes at a significance level of
Pval ≤ 0.01 were included.
Confirmatory trajectory analysis was performed using the
StemID2 algorithm version 17. Clusters with n ≥ 5 cells were
included. A threshold of Pthr = 0.01 was applied. Trajectories were
analyzed as suggested by the plotgraph function with a threshold of
scthr = 0.01. For the control-to-day7, trajectory clusters 5->4->3-
>11->14 were considered and for the control-to-day3 trajectory clus-
ters 5->4->3->6. For pseudotemporal ordering, default parameters
were used (Trapnell et al, 2014). Heatmaps were visualized using
the pheatmap R package version 1.0.12.
Human tissue
Whole human eyes (ciliary body melanoma) or eye tissue (CNV
membrane) were taken with consent with the patients during
surgery at the Eye Clinic, University Medical Center Freiburg. MACE
RNA Sequencing was performed on four FFPE CNV membranes that
were extracted from patients with neovascular Four age-matched
FFPE RPE-choroidal specimens were obtained from the macular
region of enucleated eyes suffering from ciliary body melanoma
served as controls. The macular RPE and choroid was unaffected in
these eyes as confirmed by routine histology. FFPE tissue was sliced
with 7 µm thickness and placed on glass slides. For immunohisto-
chemistry, deparaffinization was performed (15 min xylol followed
by descending ethanol concentration, 2× for 1 min for each concen-
tration (100, 96, 70%)) and finally aqua dest at room temperature.
Next, citrate buffer (pH = 6) was applied for 40 min at 95°C. The
following steps were performed in an Autostainer (Agilent Dako,
Santa Clara, CA, USA) with the Dako REALTM EnVisionTM Detection
System Kit (K406511-2, Agilent Dako). Peroxidase blocking reagent
(5 min) was rinsed with Tris buffer (0.5 M TRIS, 9% NaCl, 0.5%
Tween 20). Primary antibodies (Anti-HLA-DP, DQ, DR, M0775,
clone CR3/43, 1:400, Agilent Dako, Santa Clara, CA, USA) were
incubated for 30 min, washed with Tris, treated with secondary
antibody for 20 min, and finally visualized by diaminobenzidin
according to the manufacturer’s instructions for 5–10 min. After
rinsing with aqua dest, nuclei were counterstained with hema-
toxylin–eosin for 15 s. After washing with water, the deparaffination
protocol was conducted in reverse order before embedding in Vitro-
Clud (R. Langenbrinck GmbH, Emmendingen, Germany).
RNA sequencing using massive analysis of cDNA ends (MACE)
Total RNA was isolated from formalin-fixed and paraffin-embedded
(FFPE) sections of all specimens using the Quick-RNA FFPE Kit
(Zymo Research, USA). Following a DNAse I digestion using the
Baseline-ZERO kit (Epicentre, USA), the RNA concentration was
measured with the Qubit RNA HS Assay Kit on a Qubit Fluorometer
(Life Technologies, USA). The RNA quality was determined with the
RNA Pico Sensitivity Assay on a LabChip GXII Touch (PerkinElmer,
USA). The fragment size of all RNA samples ranged between 120
and 150 bp. The preparation of massive analysis of cDNA ends
(MACE) libraries was carried out using 1 µg of total RNA, as previ-
ously described (Zajac et al, 2015). The barcoded libraries (four CNV
membranes and four control samples) were sequenced simultane-
ously on the NextSeq 500 (Illumina, USA) with 1 × 75 bp. Illumina
sequence reads and were processed with an in-house analysis pipe-
line (GeneXPro, Germany), including TrueQuant PCR bias elimina-
tion and mapping against the human reference genome. For MACE
analysis, normalization and test for differential gene expression were
calculated using the DEGseq (Wang et al, 2010). Differential gene
expression was quantified as the log2 ratio of the normalized values
between the two libraries (CNV vs. control). The sequencing data
reported in the current article have been deposited in the Gene
Expression Omnibus database under the accession number
GSE146887 (Schlecht et al, 2020).
Statistical analysis
Statistical analysis was performed using GraphPad Prism (GraphPad
Software, version 6.0, La Jolla, USA). Data were tested for normality
applying the Kolmogorov–Smirnov test. If normality was given, an
unpaired t-test was applied or one-way ANOVA, if not indicated
otherwise. If the data did not meet the criteria of normality, the
Mann–Whitney or Kruskal–Wallis test was applied. Differences were
considered significant when P-value < 0.05.
Data availability
The sequencing data reported in the current article have been
deposited in the Gene Expression Omnibus database under the
accession numbers GSE160845 (mouse bulk RNA-seq; https://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE160845) and
GSE160797 (mouse single-cell RNA-seq; https://www.ncbi.nlm.nih.
gov/geo/query/acc.cgi?acc=GSE160797).
Expanded View for this article is available online.
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